[House Report 107-182]
[From the U.S. Government Publishing Office]
107th Congress Report
HOUSE OF REPRESENTATIVES
1st Session 107-182
======================================================================
URGING INCREASED FEDERAL FUNDING FOR JUVENILE (TYPE 1) DIABETES
RESEARCH
_______
August 1, 2001.--Referred to the House Calendar and ordered to be
printed
_______
Mr. Tauzin, from the Committee on Energy and Commerce, submitted the
following
R E P O R T
[To accompany H. Con. Res. 36]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the concurrent resolution (H. Con. Res. 36) urging increased
Federal funding for juvenile (Type 1) diabetes research, having
considered the same, report favorably thereon with amendments
and recommend that the concurrent resolution as amended be
agreed to.
CONTENTS
Page
Amendment........................................................ 1
Purpose and Summary.............................................. 2
Background and Need for Legislation.............................. 2
Hearings......................................................... 2
Committee Consideration.......................................... 2
Committee Votes.................................................. 3
Committee Oversight Findings..................................... 3
Statement of General Performance Goals and Objectives............ 3
New Budget Authority, Entitlement Authority, and Tax Expenditures 3
Committee Cost Estimate.......................................... 3
Congressional Budget Office Estimate............................. 3
Federal Mandates Statement....................................... 4
Advisory Committee Statement..................................... 4
Constitutional Authority Statement............................... 4
Applicability to Legislative Branch.............................. 4
Section-by-Section Analysis of the Legislation................... 4
Changes in Existing Law Made by the Bill, as Reported............ 5
AMENDMENT
The amendments strike all after the resolving clause and
strike the preamble and insert a new resolving clause and
preamble which appear in italic type in the reported concurrent
resolution. The amendments also amend the title of the
concurrent resolution.
The following shows the preamble and the subsequent
provisions of the reported concurrent resolution:
Whereas over one million Americans suffer from juvenile (type 1) diabetes,
a chronic, genetically determined, debilitating disease affecting every
organ system:
Whereas 13,000 children a year--35 each day--are diagnosed with juvenile
diabetes;
Whereas 17,000 adults a year--46 each day--are diagnosed with juvenile
diabetes;
Whereas juvenile diabetes is one of the most costly chronic diseases of
childhood;
Whereas insulin treats but does not cure this potentially deadly disease
and does not prevent the complications of diabetes, which include
blindness, heart attack, kidney failure, stroke, nerve damage, and
amputations; and
Whereas the Diabetes Research Working Group, a nonpartisan advisory board
established to advise Congress, has called for an accelerated and expanded
diabetes research program at the National Institutes of Health and has
recommended an increase in Federal funding for diabetes research at the
National Institutes of Health over each of the next five years: Now,
therefore, be it
Resolved by the House of Representatives (the Senate concurring),
That Federal funding for diabetes research should be increased annually
as recommended by the Diabetes Research Working Group so that a cure
for juvenile diabetes can be found.
The following shows the amendment to the title:
Amend the title so as to read: ``A concurrent resolution
urging increased Federal funding for juvenile (type 1) diabetes
research.''.
PURPOSE AND SUMMARY
H. Con. Res. 36 declares that Federal funding for diabetes
research should be increased so that a cure for juvenile
diabetes can be found.
BACKGROUND AND NEED FOR LEGISLATION
More than one million Americans have type 1 (juvenile)
diabetes. Type 1 diabetes is a disease which strikes children
suddenly, makes them insulin dependent for life, and carries
the constant threat of life threatening complications. Someone
is diagnosed with type 1 diabetes every hour, and this
devastating disease also afflicts adult populations. Type 1
diabetes impairs the body's ability to manufacture and use
insulin, a hormone necessary to metabolize sugar or glucose.
Most people with diabetes must take either insulin injections
or oral medications to lower blood sugar levels. When blood
sugar levels are not maintained properly, people with diabetes
are often threatened with blood sugar emergencies (either
hyperglycemia or hypoglycemia), which can be life threatening.
Even with insulin, type 1 diabetes usually results in a
drastic reduction in quality of life and shortens the average
life span by 15 years. Each year, approximately 30,000
Americans are diagnosed with type 1 diabetes, over 13,000 of
whom are children.
HEARINGS
The Subcommittee on Health held a hearing entitled,
``Advancing the Health of the American People: Addressing
Various Public Health Needs'' on June 27, 2001. The
Subcommittee heard testimony on H. Con. Res. 36 at the hearing.
The witness testifying on the bill was Mr. Larry Balthazar.
COMMITTEE CONSIDERATION
On Wednesday, July 11, 2001, the Subcommittee on Health met
in an open markup session and approved H. Con. Res. 36 for Full
Committee consideration, as amended, by voice vote, a quorum
being present. On Wednesday, July 18, 2001, the Full Committee
met in open markup session and ordered H. Con. Res. 36
favorably reported to the House, as amended, by unanimous
consent, a quorum being present.
COMMITTEE VOTES
Clause 3(b) of rule XIII of the Rules of the House of
Representatives requires the Committee to list the record votes
on the motion to report legislation and amendments thereto.
There were no record votes taken in connection with ordering H.
Con. Res. 36 reported. A motion by Mr. Tauzin to order H. Con.
Res. 36 reported to the House, as amended, was agreed to by
unanimous consent.
COMMITTEE OVERSIGHT FINDINGS
Pursuant to clause 3(c)(1) of rule XIII of the Rules of the
House of Representatives, the Committee held an oversight
hearing and made findings that are reflected in this report.
STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES
The goal of H. Con. Res. 36 is to urge increased Federal
funding for juvenile (type 1) diabetes research.
NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX EXPENDITURES
In compliance with clause 3(c)(2) of Rule XIII of the Rules
of the House of Representatives, the Committee finds that H.
Con. Res. 36, a concurrent resolution urging increased Federal
funding for juvenile (type 1) diabetes research, would result
in no new or increased budget authority, entitlement authority,
or tax expenditures or revenues.
COMMITTEE COST ESTIMATE
The Committee adopts as its own the cost estimate prepared
by the Director of the Congressional Budget Office pursuant to
section 402 of the Congressional Budget Act of 1974.
CONGRESSIONAL BUDGET OFFICE ESTIMATE
Pursuant to clause 3(c)(3) of Rule XIII of the Rules of the
House of Representatives, the following is the cost estimate
provided by the Congressional Budget Office pursuant to section
402 of the Congressional Budget Act of 1974:
U.S. Congress,
Congressional Budget Office,
Washington, DC, July 30, 2001.
Hon. W.J. ``Billy'' Tauzin,
Chairman, Committee on Energy and Commerce,
House of Representatives, Washington, DC.
Dear Mr. Chairman: The Congressional Budget Office has
prepared the enclosed cost estimates for the following
Concurrent Resolutions approved by the Committee on Energy and
Commerce:
H. Con. Res. 25, expressing the sense of the Congress
regarding tuberous sclerosis;
H. Con. Res. 36, urging increased federal funding for
juvenile (Type I) diabetes research;
H. Con. Res. 61, expressing support for a National
Reflex Sympathetic Dystrophy (RSD) Awareness Month.
If you wish further details on these estimates, we will be
pleased to provide them. The CBO staff contact is Charles
Betley.
Sincerely,
Barry B. Anderson
(For Dan L. Crippen, Director).
Enclosure.
H. Con. Res. 36--Urging increased federal funding for juvenile (Type I)
diabetes research
H. Con. Res. 36 would express the resolve of the Congress
to increase annually federal funding of research to find a cure
for juvenile diabetes, according to the recommendations of the
Diabetes Research Working Group. CBO estimates that passing H.
Con. Res. 36 would result in no significant cost to the federal
government. The resolution would not affect direct spending or
receipts; therefore, pay-as-you-go procedures would not apply.
The CBO staff contact is Charles Betley. This estimate was
approved by Peter H. Fontaine, Deputy Assistant Director for
Budget Analysis.
federal mandates statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
advisory committee statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
constitutional authority statement
Pursuant to clause 3(d)(1) of rule XIII of the Rules of the
House of Representatives, the Committee finds that the
Constitutional authority for this legislation is provided in
Article I, section 8, clause 3, which grants Congress the power
to regulate commerce with foreign nations, among the several
States, and with the Indian tribes.
applicability to legislative branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
section-by-section analysis of the legislation
This legislation expresses the sense of Congress that
Federal funding for diabetes research be increased in
accordance with the recommendations of the Diabetes Research
Working Group so that a cure for juvenile diabetes can be
found.
changes in existing law made by the bill, as reported
This legislation does not amend any existing Federal
statute.